CNCR Holdings

The Cancer Immunotherapy ETF

ETF Information as of 12/17/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
FATE THERAPEUTICS INC FATE 31189P102 176,870 $2,665,430.90 6.65%
MERCK & CO INC MRK 58933Y105 35,002 $2,633,200.46 6.57%
NOVARTIS A G NVS 66987V109 28,178 $2,416,545.28 6.03%
ASTRAZENECA PLC AZN 046353108 59,279 $2,273,349.65 5.67%
BRISTOL MYERS SQUIBB CO BMY 110122108 40,451 $2,059,764.92 5.14%
MORPHOSYS AG MOR 617760202 74,433 $1,997,781.72 4.99%
GILEAD SCIENCES INC GILD 375558103 30,302 $1,973,266.24 4.92%
ATARA BIOTHERAPEUTICS INC ATRA 046513107 46,924 $1,855,374.96 4.63%
XENCOR INC XNCR 98401F105 52,334 $1,846,343.52 4.61%
MIRATI THERAPEUTICS INC MRTX 60468T105 43,353 $1,722,848.22 4.30%
ZYMEWORKS INC ZYME 98985W102 129,658 $1,655,732.66 4.13%
BEIGENE LTD BGNE 07725L102 12,244 $1,633,839.36 4.08%
ARCUS BIOSCIENCES INC RCUS 03969F109 133,375 $1,576,492.50 3.93%
IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 163,061 $1,508,314.25 3.76%
DYNAVAX TECHNOLOGIES CORP DVAX 268158201 134,304 $1,363,185.60 3.40%
ZIOPHARM ONCOLOGY INC ZIOP 98973P101 501,632 $1,334,341.12 3.33%
NEKTAR THERAPEUTICS NKTR 640268108 37,853 $1,293,058.48 3.23%
MACROGENICS INC MGNX 556099109 95,201 $1,275,693.40 3.18%
CYTOMX THERAPEUTICS INC CTMX 23284F105 85,338 $1,242,521.28 3.10%
CELLECTIS S A CLLS 15117K103 68,787 $1,218,217.77 3.04%
FIVE PRIME THERAPEUTICS INC FPRX 33830X104 121,427 $1,143,842.34 2.85%
BLUEBIRD BIO INC BLUE 09609G100 10,834 $1,132,911.38 2.83%
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAP 00653A107 174,802 $769,128.80 1.92%
ADURO BIOTECH INC ADRO 00739L101 278,178 $731,608.14 1.83%
SORRENTO THERAPEUTICS INC SRNE 83587F202 290,872 $718,453.84 1.79%
Cash & Other Cash&Other Cash&Other 26,618.21 $26,618.21 0.07%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities